(Q37411584)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19275699%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

review article

1 reference

title

Drug targets in hepatitis B virus infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19275699%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19275699%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

author name string

Rohit Loomba

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19275699%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

publication date

1 April 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19275699%20AND%20SRC:MED&resulttype=core&format=json

Infectious disorders drug targets

23 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19275699%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19275699%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19275699%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

page(s)

105-116

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19275699%20AND%20SRC:MED&resulttype=core&format=json

Antiviral chemotherapy for chronic hepatitis B infection: lessons learned from treating HIV-infected patients

23 January 2020

cites work

1 reference

12 December 2020

A pilot study of the CY-1899 T-cell vaccine in subjects chronically infected with hepatitis B virus. The CY1899 T Cell Vaccine Study Group

1 reference

12 December 2020

A randomized, controlled study of thymosin-alpha1 therapy in patients with anti-HBe, HBV-DNA-positive chronic hepatitis B

1 reference

12 December 2020

Structural biology. The ribosome is a ribozyme

1 reference

12 December 2020

Long-term therapy of chronic hepatitis B with lamivudine.

1 reference

12 December 2020

Hepatitis B infection in China

1 reference

12 December 2020

Entecavir (Bristol-Myers Squibb).

1 reference

12 December 2020

Hepatitis B Virus Infection in Chimpanzees: Titration of Subtypes

1 reference

12 December 2020

Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C.

1 reference

12 December 2020

Hepatitis B viral genotypes: clinical relevance and molecular characteristics.

1 reference

12 December 2020

Lipopeptide vaccines--yesterday, today, and tomorrow

1 reference

12 December 2020

Immunogenicity and tolerogenicity of hepatitis B virus structural and nonstructural proteins: implications for immunotherapy of persistent viral infections

1 reference

12 December 2020

Phenylpropenamide derivatives AT-61 and AT-130 inhibit replication of wild-type and lamivudine-resistant strains of hepatitis B virus in vitro

1 reference

12 December 2020

Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice.

1 reference

12 December 2020

Activated intrahepatic antigen-presenting cells inhibit hepatitis B virus replication in the liver of transgenic mice.

1 reference

12 December 2020

Understanding the unique mechanism of L-FMAU (clevudine) against hepatitis B virus: molecular dynamics studies

1 reference

12 December 2020

Progress in DNA vaccine for prophylaxis and therapy of hepatitis B.

1 reference

12 December 2020

Inhibition of hepatitis B virus in mice by RNA interference

1 reference

12 December 2020

Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B.

1 reference

12 December 2020

Agents in clinical development for the treatment of chronic hepatitis B.

1 reference

12 December 2020

Ribozyme-mediated revision of RNA and DNA

1 reference

12 December 2020

Biochemical pharmacology of (+)- and (-)-2',3'-dideoxy-3'-thiacytidine as anti-hepatitis B virus agents

1 reference

12 December 2020

The Toll‐like receptor 7 (TLR7)‐specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily

1 reference

12 December 2020

Immunomodulatory drugs and therapeutic vaccine in chronic hepatitis B infection

1 reference

12 December 2020

Signal transduction pathways that inhibit hepatitis B virus replication

1 reference

12 December 2020

Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8

1 reference

12 December 2020

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

1 reference

12 December 2020

Hepatitis B virus infection--natural history and clinical consequences

1 reference

12 December 2020

Molecular virology of hepatitis B virus

1 reference

12 December 2020

Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrierer

1 reference

12 December 2020

Antiviral therapy in patients with chronic hepatitis B and cirrhosis

1 reference

12 December 2020

Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B.

1 reference

12 December 2020

siRNA therapeutics: big potential from small RNAs

1 reference

12 December 2020

Management of antiviral resistance in patients with chronic hepatitis B.

1 reference

12 December 2020

Impaired functional capacities of liver dendritic cells from murine hepatitis B virus (HBV) carriers: relevance to low HBV-specific immune responses

1 reference

12 December 2020

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

1 reference

12 December 2020

In vivo immunization by vaccine therapy following virus suppression by lamivudine: a novel approach for treating patients with chronic hepatitis B.

1 reference

12 December 2020

A randomized, controlled trial of combination therapy for chronic hepatitis B: comparing pegylated interferon-alpha2b and lamivudine with lamivudine alone

1 reference

12 December 2020

Lambda interferon inhibits hepatitis B and C virus replication

1 reference

12 December 2020

Effects of IL-12 and IL-18 on HBcAg-specific cytokine production by CD4 T lymphocytes of children with chronic hepatitis B infection

1 reference

12 December 2020

Inhibition of hepatitis B virus replication in 2.2.15 cells by expressed shRNA.

1 reference

12 December 2020

Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication

1 reference

12 December 2020

Toll-like receptor signaling inhibits hepatitis B virus replication in vivo.

1 reference

12 December 2020

Safety and antiviral activity of emtricitabine (FTC) for the treatment of chronic hepatitis B infection: a two-year study.

1 reference

12 December 2020

A heteroaryldihydropyrimidine activates and can misdirect hepatitis B virus capsid assembly

1 reference

12 December 2020

Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.

1 reference

12 December 2020

Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.

1 reference

12 December 2020

Inhibition of hepatitis B virus gene expression and replication by helioxanthin and its derivative

1 reference

12 December 2020

Peginterferon-alpha 2a for the treatment of hepatitis B infection

1 reference

12 December 2020

Induction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patients

1 reference

12 December 2020

Epidemiology and natural history of hepatitis B.

1 reference

12 December 2020

A dose-ranging study of the efficacy and tolerability of entecavir in Lamivudine-refractory chronic hepatitis B patients

1 reference

12 December 2020

Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers.

1 reference

12 December 2020

Therapeutic implications of hepatitis B virus genotypes.

1 reference

12 December 2020

A double-blind placebo-controlled study of emtricitabine in chronic hepatitis B.

1 reference

12 December 2020

Novel approaches to new therapies for hepatitis B virus infection.

1 reference

12 December 2020

Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.

1 reference

12 December 2020

A 12-week clevudine therapy showed potent and durable antiviral activity in HBeAg-positive chronic hepatitis B.

1 reference

12 December 2020

Peptide aptamer-mediated inhibition of target proteins by sequestration into aggresomes

1 reference

12 December 2020

Entecavir for Treatment of Lamivudine-Refractory, HBeAg-Positive Chronic Hepatitis B

1 reference

12 December 2020

DNA cleavage catalysed by the ribozyme from Tetrahymena

1 reference

12 December 2020

New developments in the treatment of chronic hepatitis B.

1 reference

12 December 2020

BAY 41-4109 has multiple effects on Hepatitis B virus capsid assembly

1 reference

12 December 2020

Successful Treatment with Peginterferon alfa-2b of HBeAg-positive HBV Non-Responders to Standard Interferon or Lamivudine

1 reference

12 December 2020

Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years

1 reference

12 December 2020

Recent advances in hepatitis B virus research: a German point of view

1 reference

12 December 2020

Viral and cellular determinants involved in hepadnaviral entry

1 reference

12 December 2020

Intracellular transport of hepatitis B virus

1 reference

12 December 2020

Hepatitis B virus morphogenesis

1 reference

12 December 2020

1 reference

12 December 2020

A randomized placebo-controlled, dose-finding study of oral LB80380 in HBeAg-positive patients with chronic hepatitis B

1 reference

12 December 2020

Glucosidase inhibitors as antiviral agents for hepatitis B and C.

1 reference

12 December 2020

In vitro activity of 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]-pyrimidine against multidrug-resistant hepatitis B virus mutants

1 reference

12 December 2020

IL-12 promotes HBV-specific central memory CD8+ T cell responses by PBMCs from chronic hepatitis B virus carriers

1 reference

12 December 2020

Management of hepatitis B: summary of a clinical research workshop

1 reference

12 December 2020

Unique antiviral mechanism discovered in anti-hepatitis B virus research with a natural product analogue

1 reference

12 December 2020

Current treatment of hepatitis B.

1 reference

12 December 2020

Hepatitis B genotypes and response to antiviral therapy: a review

1 reference

12 December 2020

Hepatitis B virus DNA is subject to extensive editing by the human deaminase APOBEC3C.

1 reference

12 December 2020

Clevudine is highly efficacious in hepatitis B e antigen-negative chronic hepatitis B with durable off-therapy viral suppression

1 reference

12 December 2020

Interactions of hepatitis B core antigen and peptide inhibitors

1 reference

12 December 2020

Telbivudine versus lamivudine in patients with chronic hepatitis B

1 reference

12 December 2020

Pradefovir: a prodrug that targets adefovir to the liver for the treatment of hepatitis B.

1 reference

12 December 2020

In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B.

1 reference

12 December 2020

Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach

1 reference

12 December 2020

The role of helioxanthin in inhibiting human hepatitis B viral replication and gene expression by interfering with the host transcriptional machinery of viral promoters

1 reference

12 December 2020

Treatment of chronic hepatitis B

1 reference

12 December 2020

Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein.

1 reference

12 December 2020

Cytidine deaminases as a weapon against retroviruses and a new target for antiviral therapy

1 reference

12 December 2020

Clinical trial: a phase II, randomized study evaluating the safety, pharmacokinetics and anti-viral activity of clevudine for 12 weeks in patients with chronic hepatitis B.

1 reference

12 December 2020

Viral hepatitis B: established and emerging therapies.

1 reference

12 December 2020

Recent advances in antiviral agents: established and innovative therapies for viral hepatitis

1 reference

12 December 2020

Entecavir therapy for lamivudine-refractory chronic hepatitis B: improved virologic, biochemical, and serology outcomes through 96 weeks

1 reference

12 December 2020

What is the optimum dose of adefovir in the treatment of chronic hepatitis B infection?

1 reference

12 December 2020

Is telbivudine superior to lamivudine for the treatment of patients with chronic hepatitis B?

1 reference

12 December 2020

A decline in hepatitis B virus surface antigen (hbsag) predicts clearance, but does not correlate with quantitative hbeag or HBV DNA levels

1 reference

12 December 2020

Inhibition of hepatitis B virus replication by Bay 41-4109 and its association with nucleocapsid disassembly

1 reference

12 December 2020

Small-molecule effectors of hepatitis B virus capsid assembly give insight into virus life cycle

1 reference

12 December 2020

Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma

1 reference

12 December 2020

Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B.

1 reference

12 December 2020

Use of animal models to study hepatitis B virus

1 reference

12 December 2020

Systemic distribution of woodchuck hepatitis virus in the tissues of experimentally infected woodchucks

1 reference

12 December 2020

Viral nucleic acid synthesis and antigen accumulation in pancreas and kidney of Pekin ducks infected with duck hepatitis B virus

1 reference

12 December 2020

Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans

1 reference

12 December 2020

Interleukin-2 downregulates hepatitis B virus gene expression in transgenic mice by a posttranscriptional mechanism.

1 reference

12 December 2020

Pilot study of natural human interleukin-2 in patients with chronic hepatitis B. Immunomodulatory and antiviral effects

1 reference

12 December 2020

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

1 reference

12 December 2020

Viral dynamics in hepatitis B virus infection

1 reference

12 December 2020

Evidence for activation of the hepatitis B virus polymerase by binding of its RNA template.

1 reference

12 December 2020

Hepadnavirus assembly and reverse transcription require a multi-component chaperone complex which is incorporated into nucleocapsids

1 reference

12 December 2020

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

1 reference

12 December 2020

Carboxypeptidase D (gp180), a Golgi-resident protein, functions in the attachment and entry of avian hepatitis B viruses

1 reference

12 December 2020

Inhibition of human hepatitis B virus replication by AT-61, a phenylpropenamide derivative, alone and in combination with (-)beta-L-2',3'-dideoxy-3'-thiacytidine

1 reference

12 December 2020

Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994

1 reference

12 December 2020

10.2174/187152609787847677

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19275699%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19275699%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

PubMed publication ID

19275699

1 reference